Home > Financial Ratios > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Core EBITDA Margin

    Back to All Ratios
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
Best 1M Momentum Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 20.1317.3015.9816.6714.51

What is the latest Core EBITDA Margin ratio of TORRENT PHARMACEUTICALS ?

The latest Core EBITDA Margin ratio of TORRENT PHARMACEUTICALS is 20.13 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar202420.13
Mar202317.30
Mar202215.98
Mar202116.67
Mar202014.51

How is Core EBITDA Margin of TORRENT PHARMACEUTICALS Trending?

Years Core EBITDA Margin % Change
Mar2024 20.13
16.36
Mar2023 17.3
8.26
Mar2022 15.98
-4.14
Mar2021 16.67
14.89
Mar2020 14.51 -

Other Financial Ratios of TORRENT PHARMACEUTICALS


Compare Core EBITDA Margin ratio of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹114,186.3 Cr 0.3% 5.6% 59.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹435,407.0 Cr 0.3% 0.2% 46% Stock Analytics
DIVIS LABORATORIES ₹157,489.0 Cr -2.7% -0.1% 58.9% Stock Analytics
CIPLA ₹117,443.0 Cr -3% -8.6% 19% Stock Analytics
DR REDDYS LABORATORIES ₹103,338.0 Cr -0.1% -3.4% 7.2% Stock Analytics
ZYDUS LIFESCIENCES ₹99,244.9 Cr 0.8% 1.8% 48.1% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

0.3%

5.6%

59.3%

SENSEX

0.7%

2.5%

17%


You may also like the below Video Courses